Setting New Standards of Clinical
Certainty in Natural Alternatives
Since its inception, Metagenics has introduced 19 innovative "firsts" that have raised the bar of quality and effectiveness in the natural healthcare industry. Building on this legacy, Metagenics' research scientists have developed another "first": the ExpresSyn Process - the most significant product development innovation in the history of natural alternatives.
The ExpresSyn Process combines:
Cell proteomic research
Safety evaluations
Human ex vivo research
Human clinical research
to demonstrate efficacy, bioavailability, and a high level of predicted safety for the new line of ExpresSyn products. The ExpresSyn Process has set a new standard of clinical certainty in natural alternatives.
